7.50
price down icon1.57%   -0.12
after-market Handel nachbörslich: 7.48 -0.02 -0.27%
loading
Schlusskurs vom Vortag:
$7.62
Offen:
$7.7
24-Stunden-Volumen:
193.28K
Relative Volume:
0.65
Marktkapitalisierung:
$638.46M
Einnahmen:
$81.18M
Nettoeinkommen (Verlust:
$-80.94M
KGV:
-6.3511
EPS:
-1.1809
Netto-Cashflow:
$-55.15M
1W Leistung:
-2.72%
1M Leistung:
+32.04%
6M Leistung:
+58.23%
1J Leistung:
+128.66%
1-Tages-Spanne:
Value
$7.40
$7.70
1-Wochen-Bereich:
Value
$7.37
$7.88
52-Wochen-Spanne:
Value
$3.10
$7.88

Sophia Genetics Sa Stock (SOPH) Company Profile

Name
Firmenname
Sophia Genetics Sa
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
415
Name
Twitter
Name
Nächster Verdiensttermin
2026-08-04
Name
Neueste SEC-Einreichungen
Name
SOPH's Discussions on Twitter

Compare SOPH vs VEEV, BTSG, TEM, HQY, TXG

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
SOPH icon
SOPH
Sophia Genetics Sa
7.50 644.42M 81.18M -80.94M -55.15M -1.1809
VEEV icon
VEEV
Veeva Systems Inc
243.75 39.23B 3.32B 941.65M 1.64B 5.6161
BTSG icon
BTSG
Brightspring Health Services Inc
61.71 11.81B 13.65B 169.86M 412.12M 1.0758
TEM icon
TEM
Tempus Ai Inc
52.10 9.85B 1.36B -302.91M -219.93M -1.7182
HQY icon
HQY
Healthequity Inc
104.73 8.82B 1.34B 230.70M 440.96M 2.6695
TXG icon
TXG
10 X Genomics Inc
56.09 7.52B 638.78M -22.66M 122.18M -0.1744

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-18 Eingeleitet Craig Hallum Buy
2024-08-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-06-27 Eingeleitet Guggenheim Buy
2023-11-29 Eingeleitet RBC Capital Mkts Outperform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-01-03 Eingeleitet BTIG Research Buy
2022-11-23 Eingeleitet Credit Suisse Neutral
2021-10-15 Fortgesetzt Cowen Outperform
2021-08-17 Eingeleitet Cowen Outperform
2021-08-17 Eingeleitet Credit Suisse Outperform
2021-08-17 Eingeleitet JP Morgan Overweight
2021-08-17 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

pulisher
10:46 AM

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript - aol.com

10:46 AM
pulisher
Aug 14, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 4,000 Shares of Stock - MarketBeat

Aug 14, 2026
pulisher
Aug 11, 2026

Sophia Genetics (SOPH) Executive Chairman Jurgi Camblong Sells 2 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 52-Week HighTime to Buy? - MarketBeat

Aug 11, 2026
pulisher
Aug 10, 2026

Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Abhimanyu Verma Sells 5,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 20,000 Shares - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Sei Investments Co. Buys Shares of 357,888 SOPHiA GENETICS SA $SOPH - MarketBeat

Aug 10, 2026
pulisher
Aug 07, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $123,930.00 in Stock - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

SOPH (NASDAQ: SOPH) insider schedules 22,000-share sale under 10b5-1 plan - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

SOPHiA GENETICS (SOPH) insider plans Rule 144 sale after 10b5-1 trades - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

Sophia Genetics CSO Zhenyu Xu disposes of USD 170,872 in common shares - Bitget

Aug 07, 2026
pulisher
Aug 07, 2026

SOPHiA GENETICS Q3 EPS Estimate Lowered by HC Wainwright - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

Three Swiss biotechs widen their reach into pharma, paediatrics and lung disease - Startupticker.ch

Aug 07, 2026
pulisher
Aug 07, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 3,000 Shares - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

HC Wainwright Predicts Reduced Earnings for SOPHiA GENETICS - MarketBeat

Aug 06, 2026
pulisher
Aug 05, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 10,000 Shares - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $138,400.00 in Stock - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

BTIG raises Sophia Genetics stock price target on CDx deals By Investing.com - Investing.com South Africa

Aug 05, 2026
pulisher
Aug 05, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

SOPH Stock Price and Chart — NASDAQ:SOPH - tradingview.com

Aug 05, 2026
pulisher
Aug 05, 2026

BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

SOPHiA GENETICS Updates Investors With Q2 2026 Form 6-K Filing - The Globe and Mail

Aug 05, 2026
pulisher
Aug 05, 2026

BTIG raises Sophia Genetics stock price target on CDx deals - Investing.com

Aug 05, 2026
pulisher
Aug 05, 2026

SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics - Yahoo Finance

Aug 05, 2026
pulisher
Aug 04, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Shares Up 10.5%Here's Why - MarketBeat

Aug 04, 2026
pulisher
Aug 04, 2026

Jurgi Camblong (SOPH) plans 20,000-share sale and details 10b5-1 trades - Stock Titan

Aug 04, 2026
pulisher
Aug 04, 2026

SOPHiA GENETICS (SOPH) insider Zhenyu Xu plans 10,000-share stock sale - Stock Titan

Aug 04, 2026
pulisher
Aug 04, 2026

Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ... - Yahoo! Finance Canada

Aug 04, 2026
pulisher
Aug 04, 2026

SOPHiA GENETICS Q2 Earnings Call Highlights - MarketBeat

Aug 04, 2026
pulisher
Aug 04, 2026

Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies - marketscreener.com

Aug 04, 2026
pulisher
Aug 04, 2026

SOPH: Q2 revenue up 27% year-over-year, guidance raised, and major biopharma wins secured - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

Earnings call transcript: SOPHiA GENETICS tops revenue estimates in Q2 2026 - Investing.com

Aug 04, 2026
pulisher
Aug 04, 2026

SOPH Looks 11.8% Overvalued on GF Value™ - GuruFocus

Aug 04, 2026
pulisher
Aug 04, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Issues Quarterly Earnings Results - MarketBeat

Aug 04, 2026
pulisher
Aug 04, 2026

Sophia Genetics SA reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

SOPH: Q2 2026 revenue rose 27% YoY, with strong U.S. and Liquid Biopsy growth and improved EBITDA loss - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

BRIEF-SOPHiA GENETICS SA Q2 Revenue USD 23.3 Million - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

SOPHiA GENETICS Reports Second Quarter 2026 Results - PR Newswire

Aug 04, 2026
pulisher
Aug 04, 2026

Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Aug 04, 2026
pulisher
Aug 03, 2026

H.C. Wainwright reiterates Sophia Genetics stock rating ahead of results - Investing.com

Aug 03, 2026
pulisher
Aug 03, 2026

H.C. Wainwright reiterates Sophia Genetics stock rating ahead of results By Investing.com - Investing.com South Africa

Aug 03, 2026
pulisher
Jul 31, 2026

Sophia Genetics SA expected to post a loss of 21 cents a shareEarnings Preview - TradingView

Jul 31, 2026
pulisher
Jul 28, 2026

Jurgi Camblong Sells 20,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

Jul 28, 2026
pulisher
Jul 28, 2026

SOPHiA GENETICS (SOPH) Expected to Post Earnings on Tuesday - MarketBeat

Jul 28, 2026
pulisher
Jul 28, 2026

SOPHiA Genetics CMO Philippe Menu Sells 5,000 Shares via Rule 10b5-1 Trading Plan on July 27, 2026 - Kalkine Media

Jul 28, 2026
pulisher
Jul 27, 2026

Sophia Genetics SA (SOPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Sophia Genetics SA (SOPH) Cash Flow - TradingKey

Jul 26, 2026
pulisher
Jul 24, 2026

Sophia Genetics SA (SOPH) Institutional Confidence - TradingKey

Jul 24, 2026

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$22.00
price up icon 1.10%
$42.08
price up icon 35.70%
$24.80
price down icon 6.73%
WAY WAY
$24.78
price down icon 1.20%
$88.49
price up icon 1.22%
TXG TXG
$56.09
price down icon 3.54%
Kapitalisierung:     |  Volumen (24h):